Search by Drug Name or NDC
NDC 55150-0284-10 Cisatracurium Besylate 10 mg/5mL Details
Cisatracurium Besylate 10 mg/5mL
Cisatracurium Besylate is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Eugia US LLC. The primary component is CISATRACURIUM BESYLATE.
Product Information
| NDC | 55150-0284 |
|---|---|
| Product ID | 55150-284_17bd5e7a-d7ad-4a4f-aba1-51fb73fb502b |
| Associated GPIs | 74200013102014 |
| GCN Sequence Number | 024614 |
| GCN Sequence Number Description | cisatracurium besylate VIAL 2 MG/ML INTRAVEN |
| HIC3 | S7A |
| HIC3 Description | NEUROMUSCULAR BLOCKING AGENTS |
| GCN | 32771 |
| HICL Sequence Number | 010278 |
| HICL Sequence Number Description | CISATRACURIUM BESYLATE |
| Brand/Generic | Generic |
| Proprietary Name | Cisatracurium Besylate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Cisatracurium Besylate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/5mL |
| Substance Name | CISATRACURIUM BESYLATE |
| Labeler Name | Eugia US LLC |
| Pharmaceutical Class | Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA209665 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 55150-0284-10 (55150028410)
| NDC Package Code | 55150-284-10 |
|---|---|
| Billing NDC | 55150028410 |
| Package | 10 VIAL, SINGLE-DOSE in 1 CARTON (55150-284-10) / 5 mL in 1 VIAL, SINGLE-DOSE (55150-284-01) |
| Marketing Start Date | 2020-10-27 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |